Medical science monitor basic research, cilt.20, ss.105-11, 2014 (Scopus)
Background: Phosphodiesterase (PDE) inhibitors in the central nervous system have been shown to stimulate neuronal functions and increase neurogenesis in Alzheimer disease (AD) patients.